Cammarota, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 13.854
NA - Nord America 13.809
AS - Asia 11.611
SA - Sud America 2.293
AF - Africa 268
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 35
Totale 41.906
Nazione #
US - Stati Uniti d'America 13.398
DE - Germania 5.738
SG - Singapore 5.280
CN - Cina 2.875
BR - Brasile 1.870
IT - Italia 1.840
SE - Svezia 1.575
VN - Vietnam 1.040
FR - Francia 1.036
UA - Ucraina 845
GB - Regno Unito 697
IE - Irlanda 485
IN - India 412
PL - Polonia 401
FI - Finlandia 372
JP - Giappone 353
ID - Indonesia 352
RU - Federazione Russa 272
HK - Hong Kong 252
TR - Turchia 209
CA - Canada 187
AR - Argentina 165
MX - Messico 125
NL - Olanda 125
BD - Bangladesh 122
IQ - Iraq 115
ES - Italia 94
KR - Corea 91
BE - Belgio 87
ZA - Sudafrica 60
PK - Pakistan 59
EC - Ecuador 56
VE - Venezuela 52
AT - Austria 50
CO - Colombia 49
SA - Arabia Saudita 48
CH - Svizzera 41
UZ - Uzbekistan 41
MA - Marocco 36
CZ - Repubblica Ceca 35
IR - Iran 34
JO - Giordania 33
TN - Tunisia 33
IL - Israele 32
CL - Cile 31
KE - Kenya 30
AE - Emirati Arabi Uniti 29
AU - Australia 29
LT - Lituania 28
PH - Filippine 28
EU - Europa 27
PY - Paraguay 25
EG - Egitto 23
KZ - Kazakistan 20
NP - Nepal 19
AZ - Azerbaigian 18
DZ - Algeria 17
PA - Panama 17
RO - Romania 17
JM - Giamaica 16
PT - Portogallo 16
PE - Perù 15
BH - Bahrain 14
CI - Costa d'Avorio 14
OM - Oman 14
TW - Taiwan 14
BO - Bolivia 13
UY - Uruguay 13
CR - Costa Rica 12
MY - Malesia 12
GR - Grecia 11
HR - Croazia 11
LK - Sri Lanka 11
TH - Thailandia 11
HU - Ungheria 10
LB - Libano 10
RS - Serbia 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
GE - Georgia 9
AL - Albania 8
NG - Nigeria 8
BY - Bielorussia 7
TT - Trinidad e Tobago 7
BB - Barbados 6
BG - Bulgaria 6
HN - Honduras 6
KG - Kirghizistan 6
KW - Kuwait 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
SY - Repubblica araba siriana 6
AO - Angola 5
CY - Cipro 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
BZ - Belize 4
DK - Danimarca 4
Totale 41.801
Città #
Singapore 2.737
Chandler 1.776
Ashburn 1.464
San Jose 1.358
Jacksonville 487
Beijing 478
Dublin 477
San Mateo 383
Nürnberg 378
Ann Arbor 359
Ho Chi Minh City 346
Hefei 327
Jakarta 318
Lauterbourg 315
Los Angeles 302
Nanjing 302
Tokyo 302
New York 300
Rome 298
Warsaw 282
Hanoi 254
Milan 240
Woodbridge 231
Boston 227
Hong Kong 227
Wilmington 226
Munich 215
Frankfurt am Main 193
Cattolica 188
Marseille 168
Dearborn 167
Princeton 152
São Paulo 148
Houston 147
Moscow 138
Fairfield 136
Izmir 134
Seattle 133
The Dalles 127
St Louis 126
Chicago 125
Redwood City 124
Dallas 115
Nanchang 113
Council Bluffs 108
Buffalo 105
Helsinki 105
Santa Clara 95
Kent 89
Lawrence 89
Shanghai 86
Seoul 84
Boardman 82
Brussels 79
Kraków 75
London 75
Turku 75
Shenyang 74
Hangzhou 71
Fuzhou 68
Rio de Janeiro 65
Orem 62
Guangzhou 59
Lancaster 59
Redmond 59
Nuremberg 58
Paris 58
Bremen 57
Hebei 57
Brooklyn 56
Verona 55
Mountain View 54
Leawood 52
Da Nang 51
Pune 50
Belo Horizonte 49
Tianjin 49
Zhengzhou 49
Baghdad 48
Phoenix 48
Denver 47
Kunming 47
Changsha 46
Toronto 46
Atlanta 45
Stockholm 45
Las Vegas 44
University Park 44
Montreal 41
Amsterdam 40
Cambridge 40
Haiphong 40
San Francisco 39
Düsseldorf 38
Norwalk 37
Fremont 36
Johannesburg 36
North Bergen 35
Chennai 34
Amman 33
Totale 20.311
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 507
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 432
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 429
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 422
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 370
Consorzio di probiotici / Probiotic mixture 364
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 305
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 297
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 269
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 269
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 265
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 258
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 250
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 245
Wheat desensitization treatment in patients with gluten sensitivity 242
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 240
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 231
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 229
-High prevalence of celiac disease in patients with lactose intolerance 229
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 228
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 222
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 219
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 215
The role of diet on gut microbiota composition 214
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 212
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 210
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 208
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 208
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 207
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 207
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 206
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 206
(gc)Association of laryngeal cancer with previous gastric resection. 203
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 203
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 202
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 200
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 199
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 197
Celiac disease: what's new about it? 193
Fecal microbiota transplantation: Past, present and future perspectives 191
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 190
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 189
. Adverse reactions to food: allergies and intolerances. 188
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 186
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 185
Can chronic gastritis cause increase of fecal calprotectin concentrations? 182
A) Association of laryngeal cancer with previous gastric resection 182
Gut microbiome, big data and machine learning to promote precision medicine for cancer 182
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 179
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 179
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 177
Classification of malabsorption syndromes. 175
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 174
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 174
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 174
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 173
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 171
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 170
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 170
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 170
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 168
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 167
[Helicobacter pylori infection: from gastric to systemic disease] 166
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 166
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 166
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 164
Histamine-producing bacteria and their role in gastrointestinal disorders 164
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 164
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 164
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 163
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 163
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 162
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 162
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 160
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 160
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 159
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 159
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 158
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 158
Microscopic colitis 158
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 157
gc) Tired legs a gut diagnosis 157
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 156
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 156
European consensus conference on faecal microbiota transplantation in clinical practice 156
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 155
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 155
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 155
Faecal calprotectin concentrations in untreated coeliac patients 155
Gluten-related Recurrent Peripheral Facial Palsy 154
gastroesophageal reflux disease: facts and uncertaines 154
Levofloxacin based regimens for the eradication of Helicobacter pylori 153
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 153
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 152
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 152
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 151
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 149
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 149
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 148
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 148
Totale 20.089
Categoria #
all - tutte 160.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021462 0 0 0 0 0 0 0 0 0 0 395 67
2021/20222.093 117 185 57 129 130 89 39 337 97 95 388 430
2022/20234.882 628 658 365 732 320 599 247 386 596 94 159 98
2023/20242.645 133 704 90 173 119 318 175 95 70 156 322 290
2024/20255.946 148 198 470 167 456 189 165 326 831 588 1.257 1.151
2025/202615.099 2.423 534 951 1.672 2.551 1.127 2.691 806 1.084 1.128 132 0
Totale 42.400